Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate

Strahlentherapie und Onkologie

Volumn 182, Issue 12, 2006, Pages 721-726

  Guckenberger, Matthias ^a   Pohl, Fabian ^b   Baier, Kurt ^a   Meyer, Juergen ^a   Koelbl, Oliver ^b   Flentje, Michael ^a   Vordermark, Dirk ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Dose volume histogram; IMRT; Prostate; Rectal volume; Rectal wall

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDICAL ASSESSMENT; ORGAN SIZE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; RISK ASSESSMENT; TARGET ORGAN; TREATMENT PLANNING;

FEMUR HEAD; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RETROSPECTIVE STUDIES; SEMINAL VESICLES; STATISTICS; TOMOGRAPHY, SPIRAL COMPUTED; URINARY BLADDER;

EID: 33845367570     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1566-0     Document Type: Article

References (29)

1. Boehmer D, Kuczer D, Badakhshi H, et al. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 2006;182:277-82.
2. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92.
3. Cavey ML, Bayouth JE, Colman M, et al. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 2005;181:431-41.
4. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-72.
5. Fiorino C, Cozzarini C, Vavassori V, et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002;64:1-12.
6. Fiorino C, Gianolini S, Nahum AE. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Phys Med Biol 2003;48:2603-16.
7. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005;62:406-17.
8. Greco C, Mazzetta C, Cattani F, et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 2003;69:215-22.
9. Guckenberger M, Meyer J, Baier K, et al. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer. Radiat Oncol 2006;1:34.
10. Hoogeman MS, van Herk M, de Bois J, et al. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 2005;74:177-85.
11. Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-21.
12. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol 2001;11:215-23.
13. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001;49:685-98.
14. Koper PC, Stroom JC, van Putten WL, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 1999;43:727-34.
15. Kupelian P, Kuban D, Thames H, et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 2005;61:415-9.
16. Lee WR, Hanks GE, Hanlon AL, et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys 1996;35:251-7.
17. Leibel SA, Fuks Z, Zelefsky MJ, et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol 2003;30:596-615.
18. Martin T, Baltas D, Kurek R, et al. 3-D conformai HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 2004;180:225-32.
19. Martinez AA, Yan D, Lockman D, et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001;50:1226-34.
20. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma. Conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-55.
21. Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 2004;171:1132-6.
22. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-105.
23. Schafer M, Munter M, Sterzing F, et al. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT. Strahlenther Onkol 2005;181:587-94.
24. Schultheiss TE, Lee WR, Hunt MA, et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3-11.
25. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformai radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000;47:103-13.
26. Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
27. Vargas C, Martinez A, Kestin LL, et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:1297-308.
28. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-9.
29. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-81.